Drreddys Laboratories | RDY - Des Atouts





Des Atouts Changement Date
ANI Pharmaceuticals USD 1.49B 72.14M 2026-06
Aurora Cannabis CAD 601.09M 174.2M 2026-03
Bayer EUR 107.29B 659M 2026-06
Canopy Growth CAD 1.12B 12.54M 2026-03
Cipla INR 424.96B 23.32B 2026-03
Corcept Therapeutics USD 888.7M 73.82M 2026-06
Drreddys Laboratories INR 579.35B 573.08B 2026-03
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Lonza CHF 18.97B 164M 2025-12
Novartis USD 122.03B 3.5B 2026-06
Pacira USD 1.24B 35.44M 2026-06
Phibro Animal Health USD 1.45B 39.56M 2026-03
Prestige Brands USD 4.57B 1.07B 2026-06
Richter Gedeon HUF 1.76T 79.96B 2026-03
Sun Pharmaceuticals INR 1.09T 50.79B 2026-03
Supernus Pharmaceuticals USD 1.43B 72.62M 2026-06
Teva Pharmaceutical Industries USD 39.86B 183M 2026-06